Most patients "minimally improved". This is a weak result.
- Forums
- ASX - By Stock
- NEU
- Ann: Phase 2 trial shows significant improvements in Angelman
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.17%
!
$14.63

Ann: Phase 2 trial shows significant improvements in Angelman, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.63 |
Change
0.450(3.17%) |
Mkt cap ! $1.815B |
Open | High | Low | Value | Volume |
$14.36 | $14.75 | $14.36 | $3.513M | 241.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 21 | $14.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.63 | 79 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 142 | 14.590 |
3 | 211 | 14.580 |
6 | 1170 | 14.570 |
6 | 1217 | 14.560 |
5 | 1410 | 14.550 |
Price($) | Vol. | No. |
---|---|---|
14.610 | 153 | 2 |
14.620 | 616 | 4 |
14.630 | 790 | 5 |
14.640 | 1433 | 9 |
14.650 | 6390 | 9 |
Last trade - 11.26am 10/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |